Novo Nordisk A/S (NVO)
49.12
+2.76
(+5.95%)
USD |
NYSE |
Dec 10, 15:55
Novo Nordisk Market Cap: 218.26B for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Evaxion AS | 40.81M |
| Ascendis Pharma A/S | 12.28B |
| Regeneron Pharmaceuticals, Inc. | 76.36B |
| Omeros Corp. | 801.88M |
| Viking Therapeutics, Inc. | 4.260B |
Market Cap Related Metrics
| PE Ratio | 14.31 |
| PS Ratio | 4.686 |
| PEG Ratio | 1.264 |
| Price to Book Value | 10.77 |
| Price to Free Cash Flow | 23.67 |
| Price | 49.12 |
| Earnings Yield | 6.99% |
| PEGY Ratio | 0.9509 |
| Operating PE Ratio | 11.05 |
| Normalized PE Ratio | 14.31 |